Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer
Wednesday, August 19, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Engineered probiotic bacteria were able to infiltrate pancreatic tumors, stimulate cancer-fighting immune cells, and slow tumor growth in animal studies. Even more strikingly, the treatment worked better when combined with chemotherapy, radiation, or immunotherapy. (via Science Daily)
Read the Full StoryThis article will expire in 18 days.
In the News...
View All Recent News
- Keto diet cut liver fat by 67% in a clinical trial
- Dogs may hold surprising clues to human longevity
- Long-term melatonin use linked to 90% higher heart failure risk
- Your sleep may be hiding an early clue to Alzheimer’s
- Scientists discover why damaged nerves struggle to heal
- Researchers followed 400,000 kids for 20 years and found a lasting pre-K advantage
- A common vape flavoring may disrupt early embryo development
- Experimental eye drops help blind mice see again
- Scientists tested 212 plant-based meat alternatives. Every one contained fungal toxins
- Scientists discover a brain “brake” that can shut down chronic pain
- Eating more ultra-processed foods may raise prostate cancer risk by 30%
- Smart nanoparticles light up brain cancer and destroy what surgery misses
- Vitamin C won’t prevent most colds, but it may do one small thing
- Childhood trauma may leave a lasting “scar” inside brain cells
- A missing color in indoor light may help prevent myopia
- What you eat before age 2 may affect your health 70 years later
- Turmeric compound may protect blood vessels from diabetes damage
- Scientists may have found a shortcut to calorie restriction’s anti-aging benefits
- Your genes may decide whether a low-carb diet sends cholesterol soaring
- Your brain may not actually “make” decisions